SciELO - Scientific Electronic Library Online

 
vol.36 número1Factores del entorno de trabajo que influyen en la ocurrencia de errores de administración de medicaciónDrogas emergentes (II): el pharming índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Anales del Sistema Sanitario de Navarra

versión impresa ISSN 1137-6627

Resumen

OUTEIRINO-FERNANDEZ, A.. Osteonecrosis of the jaw associated with bisphosphonate therapy in primary osteoporosis: Review of the literature. Anales Sis San Navarra [online]. 2013, vol.36, n.1, pp.87-97. ISSN 1137-6627.  https://dx.doi.org/10.4321/S1137-66272013000100009.

Background. The aim of this review was to study risk factors involved in osteonecrosis of the jaw after oral surgery in patients treated with bisphosphonates due to primary osteoporosis. Methods. In order to find relevant related publications, we conducted a systematic search in specialized (Cochrane Database of Systematic Reviews, Trip Database) and general (Medline, Embase, Isi Web of Knowledge) bibliographical databases. The search strategy included the terms osteonecrosis, adults and oral surgery. It was limited to papers focused on human adults undergoing dentoalveolar surgery while being treated with bisphosphonates due to primary osteoporosis, which had been published in the English or Spanish languages between January 2006 and January 2012. Systematic reviews, meta-analyses, practice guidelines, randomized clinical trials and case report series were included. Results. Fourteen papers (case report series) including 43 cases of osteonecrosis of the jaw were selected. Jaw and extraction were the most frequent localization and dental procedure related to the lesions. Mean age of patients was 71.94 years, with lesions being more frequent among women. Alendronate was the bisphosphonate used in the majority of cases, with a mean duration of treatment before osteonecrosis of the jaw appeared of 48.25 months. Conclusions. Well-designed, prospective and retrospective studies are needed to evaluate the real weight of each of those factors considered to entail a potential risk of osteonecrosis of the jaw.

Palabras clave : Osteonecrosis; Osteoporosis; Bisphosphonate; Oral surgery.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons